SEC Form 4/A · accession 0001232524-17-000051
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Feb 27, 2017
Accepted (ET)
Mar 6, 2017 · 6:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | holding | — | — | — | 34,236 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 amends the Form 4 filed on March 1, 2017. Due to a technical error, the amount of securities beneficially owned by the Reporting Person following the Reported Transaction in Table I was overstated by 35,000 shares.